SANDOSTATIN LAR 20 mg powder and solvent for suspension for injection Malta - angličtina - Medicines Authority

sandostatin lar 20 mg powder and solvent for suspension for injection

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - octreotide - powder and solvent for suspension for injection - octreotide 20 mg - pituitary and hypothalamic hormones and analogues

SANDOSTATIN LAR 30 mg powder and solvent for suspension for injection Malta - angličtina - Medicines Authority

sandostatin lar 30 mg powder and solvent for suspension for injection

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - octreotide - powder and solvent for suspension for injection - octreotide 30 mg - pituitary and hypothalamic hormones and analogues

LUTATHERA 370 MBqML SOLUTION FOR INFUSION Izrael - angličtina - Ministry of Health

lutathera 370 mbqml solution for infusion

novartis israel ltd - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide - lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep nets) in adults.

LUTATHERA 370 MBqML SOLUTION FOR INFUSION Izrael - angličtina - Ministry of Health

lutathera 370 mbqml solution for infusion

marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide - lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep nets) in adults.

LUTATHERA 370 MBqML SOLUTION FOR INFUSION Izrael - angličtina - Ministry of Health

lutathera 370 mbqml solution for infusion

marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide - lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep nets) in adults.

LUNET - SRY Izrael - angličtina - Ministry of Health

lunet - sry

s.r.y. (medical services ) ltd, israel - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 600 mbq/ml - lutetium (177lu) oxodotreotide - for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep-nets) in adults.

XERMELO 250 MG Izrael - angličtina - Ministry of Health

xermelo 250 mg

medison pharma ltd - telotristat ethyl as etiprate - film coated tablets - telotristat ethyl as etiprate 250 mg - xermelo is indicated for the treatment of carcinoid syndrome diarrhoea in combination with somatostatin analogue (ssa) therapy in adults inadequately controlled by ssa therapy.

SOMAVERT 10 MG Izrael - angličtina - Ministry of Health

somavert 10 mg

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 10 mg - pegvisomant - pegvisomant - treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

SOMAVERT 15 MG Izrael - angličtina - Ministry of Health

somavert 15 mg

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 15 mg - pegvisomant - pegvisomant - treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not narmalize igf-i concentrations or was not tolerated.

SOMAVERT 20 MG Izrael - angličtina - Ministry of Health

somavert 20 mg

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 20 mg - pegvisomant - pegvisomant - treatment of adult patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not narmalize igf-i concentrations or was not tolerated.